Sitagliptin 50mg + Metformin Hydrochloride 500mg Tablets
Therapeutic Category: Oral Antidiabetic Medicine
Sitagliptin + Metformin
50mg / 500mg
Type 2 Diabetes
Oral
Sitacure-M 50/500 is an oral antidiabetic combination medicine containing Sitagliptin 50mg and Metformin Hydrochloride 500mg. It is used as part of an overall treatment plan for adults with type 2 diabetes mellitus.
The combination contains two medicines with complementary mechanisms that help regulate blood glucose levels. Treatment should be used together with appropriate diet, physical activity and professional medical advice.
Each Sitacure-M 50/500 tablet contains the following active ingredients:
Sitagliptin 50mg
Metformin Hydrochloride 500mg
Sitacure-M 50/500 may be prescribed to help improve blood glucose control in adults with type 2 diabetes mellitus.
It may be used as part of a comprehensive diabetes management plan that includes appropriate diet, physical activity and monitoring as advised by a healthcare professional.
Sitacure-M 50/500 combines two active ingredients that work through complementary mechanisms involved in blood glucose regulation.
Sitagliptin is a DPP-4 inhibitor. It helps regulate blood glucose through incretin-related pathways, supporting glucose-dependent insulin release and reducing glucagon secretion.
Metformin is a biguanide medicine. It primarily reduces glucose production by the liver and improves the body's response to insulin.
The appropriate dose of Sitacure-M 50/500 should be determined by a qualified healthcare professional. The prescribed treatment may depend on previous diabetes therapy, blood glucose control, kidney function, tolerability and other medical factors.
Sitagliptin and Metformin combination medicines are generally administered with meals. Always follow the exact dosage and administration instructions provided by your doctor or pharmacist.
Do not change the prescribed dose or stop treatment without consulting your healthcare professional.
Some patients taking Sitacure-M 50/500 may experience side effects. Gastrointestinal symptoms may occur with Metformin-containing treatment.
Contact your doctor or healthcare professional if symptoms are severe, persistent or unusual.
Before using Sitacure-M 50/500, inform your healthcare professional about your medical history and all prescription medicines, non-prescription medicines, vitamins and supplements you are taking.
Particular attention may be required in patients with kidney problems, liver disease, heart conditions or a history of pancreatitis.
Kidney function is an important consideration when using Sitagliptin and Metformin combination medicines. Renal function should be assessed and monitored as clinically appropriate.
Acute pancreatitis has been reported with Sitagliptin-containing medicines. Seek medical advice if persistent or severe abdominal pain develops.
Metformin is associated with a rare but serious risk of lactic acidosis. Certain conditions, including significant renal impairment, may increase the risk.
Sitacure-M 50/500 should not be used when Sitagliptin or Metformin is contraindicated. Consult a qualified healthcare professional before starting treatment.
Tell your doctor about all medicines, vitamins and dietary supplements that you currently take.
Certain medicines may affect blood glucose levels, kidney function or the safety of diabetes treatment. Your healthcare professional can determine whether additional monitoring or treatment adjustment is required.
Sitacure-M 50/500 is an oral antidiabetic combination tablet containing Sitagliptin 50mg and Metformin Hydrochloride 500mg. It is used as part of a treatment plan for adults with type 2 diabetes mellitus.
Each tablet contains Sitagliptin 50mg and Metformin Hydrochloride 500mg.
Sitacure-M 50/500 may be prescribed to help improve blood glucose control in adults with type 2 diabetes mellitus as part of an appropriate treatment plan.
Sitagliptin is a DPP-4 inhibitor, while Metformin is a biguanide. Both medicines work through complementary mechanisms involved in blood glucose regulation.
Possible side effects may include nausea, diarrhoea, stomach discomfort, headache and reduced appetite. Consult a healthcare professional if symptoms are severe or persistent.
Sitagliptin and Metformin combination medicines are generally taken with meals. Always follow the instructions provided by your doctor or pharmacist.
Do not stop or change diabetes treatment without consulting your doctor. Your healthcare professional should determine the appropriate duration of treatment.
The information provided on this page is for general educational and informational purposes only. It is not intended to replace the advice, diagnosis or treatment provided by a qualified healthcare professional.
Sitacure-M 50/500 should be used only as directed by a qualified healthcare professional. Always refer to approved product information and consult your doctor or pharmacist for individual medical advice.